Kimberly Wehger
Chief Tech/Sci/R&D Officer en ARVINAS, INC. .
Perfil
Kimberly Wehger es Vicepresidenta de Tecnología de la Información en Arvinas, Inc. Anteriormente, la Sra. Wehger fue Directora de Información y Vicepresidenta de New Haven Pharmaceuticals, Inc., Directora de Compromiso Empresarial en Alexion Pharmaceuticals, Inc. y Directora de Prácticas de Servicios Gestionados de I+D en Veeva Systems, Inc. Se licenció en la Universidad Estatal de Nueva York en Binghamton y se graduó en la Universidad Estatal del Sur de Connecticut.
Cargos activos de Kimberly Wehger
| Empresas | Cargo | Inicio |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Kimberly Wehger.
| Empresas | Cargo | Fin |
|---|---|---|
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| VEEVA SYSTEMS INC. | Corporate Officer/Principal | - |
Formación de Kimberly Wehger.
| Southern Connecticut State University | Graduate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| VEEVA SYSTEMS INC. | Technology Services |
| ARVINAS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Kimberly Wehger
